Sympathoadrenal Precursors Research Articles

Adrenal Medullary Nodules in Beckwith-Wiedemann Syndrome Resemble Extra-Adrenal Paraganglia.

Clues to mechanisms regulating development and tumorigenesis may be provided by studies of unusual diseases. Beckwit-Wiedemann syndrome (BWS) is a rare congenital disorder apparently related to abnormal regulation of insulin-like growth factor-2 (IGF-2) production. IGF2 mRNA has been previously localized to the chief cells of extra-adrenal paraganglia and to adult, but not fetal, adrenal medulla. Expression of IGF-2 by neuroblastomas has been hypothesized to reflect extra-adrenal paraganglionic differentiation. In the adrenals of a fetus with 8W5, we have observed both increased numbers of chromaffin cells and organoid nodules resembling extra-adrenal paraganglia. Immunoreactive IGF-2 was observed in both cell types, but was also observed in chromaffin cells in the normal fetal adrenal. The findings suggest autocrine or paracrine influences of IGF-2 in regulating the number and phenotype of cells derived from sympathoadrenal precursors in the developing adrenal medulla as well as in extra-adrenal paraganglia. These results have implications for the interpretation of data from neuroblastoma studies.

Cloning and expression of PCPTP1 encoding protein tyrosine phosphatase

A novel cDNA encoding PTP (protein tyrosine phosphatase) was cloned from PC12h cells and designated as PCPTP1 (gene encoding PC12 protein Tyr phosphatase). The longest open reading frame (ORF) of this clone encodes a 656-amino-acid (aa) protein with a single PTP catalytic domain. Western blot analysis using a polyclonal Ab (antibody) raised against the cytoplasmic region of PCPTP1 detected two products, a major 65-kDa and minor 42-kDa protein, designated PCPTP1-MFI and PCPTP1-MVQ, respectively, in PC12h cells. These two proteins correspond to the products translated from the second and fifth methionine of PCPTPI, respectively. The bacterially expressed GST::PCPTP1-MVQ fusion protein had phosphatase activity with pNPP (p-nitrophenyl phosphate) as a substrate. Alignment of the aa sequence of PCPTP1-MVQ with those of other PTP showed the highest similarity to STEP and LC-PTP/HePTP, with 54 and 51 % identity, respectively. Northern blot analysis showed only one 3.9-kb transcript in PC12h cells, indicating that PCPTP1 corresponds to this 3.9-kb transcript. The 3.9-kb PCPTPI mRNA was detected in the brain and adrenal gland, but not in other non-neuronal tissues in adult rats. Two other transcripts of 3.3 and 1.7 kb were also detected in brain. NGF (nerve growth factor) and glucocorticoid are known to bimodally regulate the cell fate decision of sympathoadrenal precursors like PC12 cells, with NGF promoting the neuronal phenotype and glucocorticoid promoting the chromaffin phenotype. Still, both agents decreased the level of PCPTPI mRNA in PC12h cells. Therefore, it is likely that the decrease in the level of PCPTP1 mRNA might be associated or correlated with cell differentiation in PC12h cells.

MAH Cells and the Development of Rat Sympathetic Neurons

The generation of cell lines in the sympathoadrenal lineage has greatly facilitated our understanding of how precursor cells that do not respond to NGF give rise to mature NGF-dependent neurons. The neuronal developmental pathway in this lineage has been worked out by studying both primary precursor cells in culture and the v-myc-immortalized MAH cell line. MAH cells were established by retroviral infection of immunoisolated rat sympathoadrenal precursor cells. These cells have many of the characteristics of primary progenitor cells including neural precursor morphology, antigenic profile, and response to growth factors. MAH cells are able to recapitulate sympathetic development, giving rise to mature, postmitotic, NGF-dependent neurons. These cells have provided a model system for studying the factors, receptors, and modulating influences that play a role in the development of sympathetic neurons.

Lectin binding distinguishes between neuroendocrine and neuronal derivatives of the sympathoadrenal neural crest.

Lectin cytochemistry was used to identify surface epitopes selectively expressed by chromaffin cell chemoreceptors (glomus cells) in the rat carotid body. Unexpectedly, these studies revealed that binding sites for peanut agglutinin (PNA; Arachis hypogea) were highly expressed by all neuroendocrine-derivatives of the sympathoadrenal neural crest, including glomus cells, small, intensely fluorescent cells, and adrenal chromaffin cells in situ. In contrast, principal sympathetic neurons did not express PNA receptors. PNA binding was inhibited by 2% galactose. To determine whether expression of PNA receptors was selectively induced by neuroendocrine differentiation of sympathoadrenal precursors, we compared PNA labeling of embryonic sympathoblasts in the presence of either nerve growth factor (NGF) or the synthetic glucocorticoid dexamethasone (DEX). DEX-treated cells, which expressed several neuroendocrine traits, bound PNA, whereas NGF-treated neuronal derivatives did not. In addition, to examine whether expression of existing PNA receptors was down-regulated by neuronal differentiation of chromaffin cells, we compared labeling of PC12 cells, which normally bind PNA, in the presence and absence of NGF. Although PC12 cells acquired characteristic neuronal morphologies in the presence of NGF, they did not lose PNA labeling, even after 8 days of NGF treatment. These findings indicate that neuronal and neuroendocrine derivatives of the sympathoadrenal lineage can be distinguished by differential expression of carbohydrate epitopes and suggest that PNA receptors are induced by neuroendocrine differentiation.

Regulation of the Quail Tyrosine Hydroxylase Gene in Neural Crest Cells by cAMP and β-Adrenergic Ligands

Expression of tyrosine hydroxylase (TH), the rate-limiting enzyme of catecholamine (CA) synthesis, was studied in quail neural crest (NC) cultures to investigate the role of environmental factors in the development of the adrenergic phenotype. First, the activity of the quail TH gene promoter was analyzed in immortalized quail NC cells by transient transfection assay. We found that chick embryo extract (CEE), which is known to trigger adrenergic differentiation of NC cells in vitro, strongly enhanced reporter gene transcription. A sequence of only 77 nucleotides, including a cAMP-responsive element, was sufficient to elicit this response. Implication of cAMP in the CEE effect was further supported by the fact that CEE produced a stimulation of adenylate cyclase activity that was sensitive to β-adrenoreceptor antagonists. Moreover, stimulation of TH gene expression by CEE could be reduced by β-adrenergic antagonists or CA-depleted extract. We have subsequently investigated the possibility that TH expression during differentiation of nontransformed NC cells could also be influenced by CA via the cAMP pathway. In dissociated cultures of 3-day-old quail sclerotomes and of 2-day-old quail trunk NC, differentiation of TH + cells was induced in the presence of forskolin, an activator of adenylate cyclase, and modulated by β-adrenoreceptor ligands. In particular, the adrenergic-promoting effect of 10% CEE on trunk NC cultures was inhibited by β-adrenoreceptor antagonists or by eliminating CA from the extract. In conclusion, these data suggest that CA (through activation of β-adrenergic receptors and cAMP production) can stimulate the initial expression of TH in cultured NC cells and enhance TH transcription in immortalized NC cells. This supports the notion that exogenous CA, which is present in the early embryo, may promote the differentiation of sympathoadrenal precursors in vivo by stimulating TH gene activity.

SA-1 Antigen Expression in Small Intensely Fluorescent Cells Is Associated with Proliferation

Sympathetic neurons, chromaffin cells, and small, intensely fluorescent (SIF) cells are thought to derive from a common sympathoadrenal precursor cell. Sympathoadrenal precursor cells and adrenal chromaffin cells have been shown to react with an antibody, SA-1; we now report that, like sympathoadrenal precursors, SIF cells during their proliferative phase transiently possess this epitope. Pre-cursors and SIF cells were identified in double-label studies of the superior cervical ganglion (SCG) using SA-1 and an antibody that identifies a noradrenergic trait, tyrosine hydroxylase (TH). At E16 when the earliest SIF precursors were detected and at birth, while postmitotic principal neurons had lost SA-1 reactivity, many SIF cells expressed both TH and SA-1. As development proceeded, the proportion of SIF cells expressing only TH increased. In addition, some small SIF-like cells possessed only SA-1 reactivity at birth. Some SIF cells at P7 possessed SA-1, but it was absent at P10 and in the adult. Bromodeoxyuridine (BrdU) was used to identify proliferating SIF cells, and SA-1+ expression was correlated with the period of SIF cell proliferation. At late embryogenesis, the proportion of SA-1+ SIF cells that possessed BrdU was relatively large (17% at E20), and decreased as SIF cell division ceased (6% at P1). Our results indicate that SA-1 is present on SIF cells when these cells are capable of cell division. In addition, mature SIF cells lack SA-1 and are therefore antigenically distinct from the sympathoadrenal precursor. These data suggest that the expression of SA-1 is correlated with the ability of sympathoadrenal cells to proliferate, in the SCG early during embryogenesis, chromaffin cells both during embryogenesis and in the adult, and SIF cells during their transient period of division in the SCG.

The sympathoadrenal lineage in avian embryos: II. Effects of glucocorticoids on cultured neural crest cells

The neural crest-derived precursors of the sympathoadrenal lineage depend on environmental cues to differentiate as sympathetic neurons and pheochromocytes. We have used the monoclonal antibody A2B5 as a marker for neuronal differentiation and antisera against catecholamine synthesis enzymes to investigate the differentiation of catecholaminergic cells in cultures of quail neural crest cells. Cells corresponding phenotypically to sympathetic neurons and pheochromocytes can be identified in neural crest cell cultures after 5–6 days in vitro. Expression of the A2B5 antigen precedes expression of immunocytochemically detectable levels of tyrosine hydroxylase in cultured neural crest cells. Glucocorticoid treatment decreases the proportion of TH + neural crest cells that express neuronal traits. We conclude that environmental cues normally encountered by sympathoadrenal precursors in vivo can influence the differentiation of a subpopulation of cultured neural crest cells in the sympathoadrenal lineage.

The determination of the adrenal medullary cell fate during embryogenesis

One subset of neural crest cells, the sympathoadrenal precursors, undergoes a switch in phenotype expression, when they invade the adrenal anlagen and become associated with adrenocortical cells. To investigate the mechanisms responsible for the conversion of noradrenaline synthesizing precursors to adrenaline producing endocrine chromaffin cells we studied the role of glucocorticoids on the initial induction of adrenaline synthesis in embryonic adrenals and cultures of highly purified chromaffin precursor cells. We could show that in vivo differentiation of rat chromaffin precursors commences between 16.3 and 17.3 days of gestation. While adrenaline and the activity of the enzyme phenylethanolamine N-methyltransferase (PNMT), which converts noradrenaline to adrenaline, were present at Embryonic Day 17.3 (E17.3), they were not detectable in E16.3 adrenals. Small amounts of corticosterone were present in E16.3 adrenals and plasma, but in parallel with the initial induction of adrenaline biosynthesis, a sharp rise in organ and plasma glucocorticoid levels occurred until E17.3. Chromaffin precursor cells, isolated at E16.3 and cultured for 4 days, failed to express PNMT activity and adrenaline. However, 0.1 n M dexamethasone was already sufficient for the initial induction of adrenaline and its synthesizing enzyme. Specific glucocorticoid binding of freshly isolated chromaffin (precursor) cells revealed a developmental increase during embryogenesis, yet no glucocorticoid binding sites were detectable in chromaffin precursor cells at E16.3. They appeared at E17.3 in parallel with the initial induction of adrenaline biosynthesis and the enormous rise of adrenal and plasma corticosterone levels. We therefore conclude that glucocorticoids are essential and sufficient to trigger the differentiation of noradrenergic sympathoadrenal precursors to adrenergic chromaffin cells after a functional glucocorticoid receptor system has been established.

Survival and neuritic growth of sympathoadrenal (chromaffin) precursor cells in vitro

Chromaffin precursor cells from embryonic rat adrenal glands were isolated at 16.3 and 20.3 days of gestation and purified by centrifugation on density gradients. Approximately 50% of the cells of both age groups that had attached to the culture substratum by 12 hr survived during a 4-day culture period in the absence of exogenous trophic factors. Nerve growth factor (NGF) and a C6 glioma-cell-conditioned medium (C6-CM) had no or a very moderate promoting effect on survival. The gluco-corticoid dexamethasone (DEX) supported the survival of 70–80% of the cells that otherwise would have died. Spontaneous neuritic growth of the sympathoadrenal precursor cells was significantly more pronounced with cells isolated at embryonic day (E) 16.3 than at E20.3. NGF had a significantly smaller promoting effect on neurite ougrowth at E16.3 than at E20.3. C6-CM induced neurite outgrowth from 25% (E16.3) and 35% (E20.3) of the surviving cells. DEX (10−6 M) completely abolished spontaneous neuritic growth and partially suppressed C6-CM-mediated fiber outgrowth. These data underscore the importance of glucocorticoids for the maintenance and development of an endocrine morphologic phenotype of sympathoadrenal precursors. They suggest that the cells may be initially driven by growth factors other than NGF into a neuronal direction and that they lack NGF-responsiveness and dependence during the early stages of their development.

Dual regulation of GAP-43 gene expression by nerve growth factor and glucocorticoids.

GAP-43 is a neural-specific protein that is believed integral to neurite growth and to the plasticity of neuronal structure. Its gene expression is regulated in vivo and correlates with periods of axonal growth. We investigated the regulation of GAP-43 gene expression in PC12 cells, which are believed to resemble precursor cells of the adrenomedullary lineage. In these cells, nerve growth factor (NGF) increases GAP-43 expression, and corticosteroids decrease it. Corticosteroids diminish GAP-43 levels even in cells already differentiated by NGF, as well as in primary neurons of the superior cervical ganglion. Neither the NGF nor the steroid effect requires new protein synthesis. Nuclear run-on experiments show that the steroid repression is mediated at the level of gene transcription but that the NGF effect is likely to be posttranscriptional. NGF and corticosteroids are known to regulate bimodally the cell fate decision of sympathoadrenal precursors, with NGF promoting the neuronal phenotype and steroids promoting the chromaffin phenotype. The regulation of GAP-43 is consistent with the notion that this gene is bimodally regulated during these cell fate decisions.

Coexpression of somatostatin-like immunoreactivity and catecholaminergic properties in neural crest derivatives: Comodulation of peptidergic and adrenergic differentiation in cultured neural crest

In the avian embryo, somatostatin-like immunoreactivity (SLI) and adrenergic characteristics appear virtually simultaneously in the developing sympathetic nervous system and adrenal medulla. We have used double-labeling techniques to show that both properties coexist in the same cells. In the quail, not only do all somatostatin-containing cells in the adrenosympathetic system exhibit tyrosine hydroxylase immunoreactivity and possess catecholamines (CA), but this coexistence of the peptidergic and adrenergic phenotypes is already present very early in ontogeny. However, not all adrenergic cells express SLI. The development of sympathoadrenal precursors can be followed in vitro. Adrenergic precursor cells, obtained from the migrating neural crest, differentiate in culture into neuron-like cells that contain SLI and CA. This coexpression can be regulated by the same factors. For instance, corticosterone and progesterone increase SLI content and CA production in the neural crest cell cultures. The ontogeny of the autonomic lineage is discussed in the light of these results.

In vivo and in vitro development of somatostatin-like-immunoreactivity in the peripheral nervous system of quail embryos

The appearance and development of somatostatin-like immunoreactivity (SLI) in the peripheral nervous system of quail embryos were studied using radioimmunoanalysis and immunocytochemistry. In vivo, no SLI is observed in neural crest cells before or during migration. SLI appears between days 3 and 4 of incubation in sympathetic ganglia, immediately following ganglion formation, and between days 4 and 5 of incubation in the adrenal gland, soon after the adrenal gland primordium first appears. The development of SLI in the adrenal gland differs from that in the sympathetic ganglia. While in the former the amount of SLI and the number of SLI-containing cells increase as the embryo ages, in the sympathetic ganglia the amount of SLI and the percentage of SLI-containing cells decrease. When migrating neural crest cells are obtained from the sclerotomal part of 3-day embryos and grown in culture, they first display SLI after 48 hr, and the amount of SLI increases thereafter. When the sympathoadrenal precursors are removed at 4 days of incubation and grown in vitro, SLI appears after 24 hr in culture and increases during the next few days. Our results demonstrate that SLI is present very early in the quail embryo and that its appearance parallels the differentiation of neural crest cells into autonomic sympathetic ganglionic cells. We also show that the differentiation of neural crest into SLI-containing cells can be reproduced in culture, thus permitting the study of peptide production and expression in vitro.